25 XP   0   0   10

Bayer AG PK
Buy, Hold or Sell?

Let's analyse Bayer together

PenkeI guess you are interested in Bayer AG PK. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bayer AG PK. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bayer AG PK

I send you an email if I find something interesting about Bayer AG PK.

Quick analysis of Bayer (30 sec.)










What can you expect buying and holding a share of Bayer? (30 sec.)

How much money do you get?

How much money do you get?
$2.58
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$9.06
Expected worth in 1 year
$2.65
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
$-3.82
Return On Investment
-50.3%

For what price can you sell your share?

Current Price per Share
$7.60
Expected price per share
$6.96 - $8.335
How sure are you?
50%

1. Valuation of Bayer (5 min.)




Live pricePrice per Share (EOD)

$7.60

Intrinsic Value Per Share

$-2.80 - $7.58

Total Value Per Share

$6.27 - $16.64

2. Growth of Bayer (5 min.)




Is Bayer growing?

Current yearPrevious yearGrowGrow %
How rich?$35.6b$41.9b-$6.2b-17.7%

How much money is Bayer making?

Current yearPrevious yearGrowGrow %
Making money-$3.1b$4.4b-$7.6b-241.1%
Net Profit Margin-6.2%8.2%--

How much money comes from the company's main activities?

3. Financial Health of Bayer (5 min.)




What can you expect buying and holding a share of Bayer? (5 min.)

Welcome investor! Bayer's management wants to use your money to grow the business. In return you get a share of Bayer.

What can you expect buying and holding a share of Bayer?

First you should know what it really means to hold a share of Bayer. And how you can make/lose money.

Speculation

The Price per Share of Bayer is $7.6. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bayer.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bayer, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.06. Based on the TTM, the Book Value Change Per Share is $-1.60 per quarter. Based on the YOY, the Book Value Change Per Share is $1.58 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.65 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bayer.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.81-10.6%-0.81-10.6%1.1415.0%-0.23-3.0%0.496.5%
Usd Book Value Change Per Share-1.60-21.1%-1.60-21.1%1.5820.8%-0.72-9.4%0.344.4%
Usd Dividend Per Share0.658.5%0.658.5%0.547.2%0.648.4%0.618.0%
Usd Total Gains Per Share-0.96-12.6%-0.96-12.6%2.1227.9%-0.07-1.0%0.9512.4%
Usd Price Per Share9.29-9.29-12.89-14.14-48.02-
Price to Earnings Ratio-11.53--11.53-11.34-12.34-41.71-
Price-to-Total Gains Ratio-9.71--9.71-6.08-4.44-57.67-
Price to Book Ratio1.02-1.02-1.21-1.41-6.53-
Price-to-Total Gains Ratio-9.71--9.71-6.08-4.44-57.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.6
Number of shares131
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.650.64
Usd Book Value Change Per Share-1.60-0.72
Usd Total Gains Per Share-0.96-0.07
Gains per Quarter (131 shares)-125.24-9.70
Gains per Year (131 shares)-500.97-38.79
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1338-839-511336-375-49
2677-1679-1012673-750-88
31015-2518-15131009-1126-127
41354-3358-20141346-1501-166
51692-4197-25151682-1876-205
62031-5037-30162019-2251-244
72369-5876-35172355-2627-283
82708-6716-40182692-3002-322
93046-7555-45193028-3377-361
103385-8394-50203364-3752-400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%24.02.00.092.3%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%17.09.00.065.4%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%26.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%21.05.00.080.8%

Fundamentals of Bayer

About Bayer AG PK

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen

Fundamental data was last updated by Penke on 2024-04-19 10:45:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Bayer AG PK.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bayer earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -6.2% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bayer AG PK:

  • The MRQ is -6.2%. The company is making a loss. -1
  • The TTM is -6.2%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-6.2%0.0%
TTM-6.2%YOY8.2%-14.4%
TTM-6.2%5Y-5.5%-0.6%
5Y-5.5%10Y1.2%-6.8%
1.1.2. Return on Assets

Shows how efficient Bayer is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • -2.4% Return on Assets means that Bayer generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bayer AG PK:

  • The MRQ is -2.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.4%TTM-2.4%0.0%
TTM-2.4%YOY3.3%-5.7%
TTM-2.4%5Y-1.9%-0.5%
5Y-1.9%10Y1.2%-3.1%
1.1.3. Return on Equity

Shows how efficient Bayer is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • -8.9% Return on Equity means Bayer generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bayer AG PK:

  • The MRQ is -8.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.9%TTM-8.9%0.0%
TTM-8.9%YOY10.7%-19.6%
TTM-8.9%5Y-8.2%-0.7%
5Y-8.2%10Y2.0%-10.2%

1.2. Operating Efficiency of Bayer AG PK.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bayer is operating .

  • Measures how much profit Bayer makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 17.7% means the company generated $0.18  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bayer AG PK:

  • The MRQ is 17.7%. The company is operating efficient. +1
  • The TTM is 17.7%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ17.7%TTM17.7%0.0%
TTM17.7%YOY12.3%+5.3%
TTM17.7%5Y10.1%+7.6%
5Y10.1%10Y11.0%-0.9%
1.2.2. Operating Ratio

Measures how efficient Bayer is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.82 means that the operating costs are $0.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bayer AG PK:

  • The MRQ is 0.823. The company is less efficient in keeping operating costs low.
  • The TTM is 0.823. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.823TTM0.8230.000
TTM0.823YOY0.855-0.032
TTM0.8235Y0.887-0.064
5Y0.88710Y0.881+0.006

1.3. Liquidity of Bayer AG PK.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bayer is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.26 means the company has $1.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bayer AG PK:

  • The MRQ is 1.259. The company is just able to pay all its short-term debts.
  • The TTM is 1.259. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.259TTM1.2590.000
TTM1.259YOY1.076+0.183
TTM1.2595Y1.163+0.096
5Y1.16310Y1.386-0.223
1.3.2. Quick Ratio

Measures if Bayer is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.94 means the company can pay off $0.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bayer AG PK:

  • The MRQ is 0.943. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.943. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.943TTM0.9430.000
TTM0.943YOY0.815+0.128
TTM0.9435Y0.876+0.067
5Y0.87610Y1.013-0.137

1.4. Solvency of Bayer AG PK.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bayer assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bayer to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.73 means that Bayer assets are financed with 73.2% credit (debt) and the remaining percentage (100% - 73.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bayer AG PK:

  • The MRQ is 0.732. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.732. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.732TTM0.7320.000
TTM0.732YOY0.688+0.044
TTM0.7325Y0.701+0.031
5Y0.70110Y0.663+0.038
1.4.2. Debt to Equity Ratio

Measures if Bayer is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 274.1% means that company has $2.74 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bayer AG PK:

  • The MRQ is 2.741. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.741. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.741TTM2.7410.000
TTM2.741YOY2.217+0.525
TTM2.7415Y2.417+0.324
5Y2.41710Y2.101+0.316

2. Market Valuation of Bayer AG PK

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bayer generates.

  • Above 15 is considered overpriced but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A PE ratio of -11.53 means the investor is paying $-11.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bayer AG PK:

  • The EOD is -9.433. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.527. Based on the earnings, the company is expensive. -2
  • The TTM is -11.527. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.433MRQ-11.527+2.094
MRQ-11.527TTM-11.5270.000
TTM-11.527YOY11.342-22.869
TTM-11.5275Y12.340-23.867
5Y12.34010Y41.708-29.368
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bayer AG PK:

  • The EOD is 21.162. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 25.859. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 25.859. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD21.162MRQ25.859-4.697
MRQ25.859TTM25.8590.000
TTM25.859YOY11.358+14.501
TTM25.8595Y18.392+7.467
5Y18.39210Y42.734-24.341
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bayer is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.02 means the investor is paying $1.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bayer AG PK:

  • The EOD is 0.839. Based on the equity, the company is cheap. +2
  • The MRQ is 1.025. Based on the equity, the company is underpriced. +1
  • The TTM is 1.025. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.839MRQ1.025-0.186
MRQ1.025TTM1.0250.000
TTM1.025YOY1.209-0.184
TTM1.0255Y1.405-0.380
5Y1.40510Y6.530-5.125
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bayer AG PK compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.602-1.6020%1.577-202%-0.716-55%0.336-576%
Book Value Per Share--9.0619.0610%10.663-15%10.047-10%9.422-4%
Current Ratio--1.2591.2590%1.076+17%1.163+8%1.386-9%
Debt To Asset Ratio--0.7320.7320%0.688+6%0.701+4%0.663+10%
Debt To Equity Ratio--2.7412.7410%2.217+24%2.417+13%2.101+30%
Dividend Per Share--0.6460.6460%0.544+19%0.642+1%0.609+6%
Eps---0.806-0.8060%1.137-171%-0.230-71%0.492-264%
Free Cash Flow Per Share--0.3590.3590%1.135-68%0.875-59%1.134-68%
Free Cash Flow To Equity Per Share--0.5980.5980%-0.021+103%-0.054+109%1.408-58%
Gross Profit Margin--5.2445.2440%-2.394+146%-2.145+141%-2.565+149%
Intrinsic Value_10Y_max--7.580--------
Intrinsic Value_10Y_min---2.795--------
Intrinsic Value_1Y_max--1.056--------
Intrinsic Value_1Y_min--0.476--------
Intrinsic Value_3Y_max--2.946--------
Intrinsic Value_3Y_min--0.784--------
Intrinsic Value_5Y_max--4.564--------
Intrinsic Value_5Y_min--0.381--------
Market Cap29865720729.600-22%36495124791.55236495124791.5520%50669553037.824-28%55569889057.536-34%188716066304.210-81%
Net Profit Margin---0.062-0.0620%0.082-175%-0.055-10%0.012-594%
Operating Margin--0.1770.1770%0.123+43%0.101+75%0.110+61%
Operating Ratio--0.8230.8230%0.855-4%0.887-7%0.881-7%
Pb Ratio0.839-22%1.0251.0250%1.209-15%1.405-27%6.530-84%
Pe Ratio-9.433+18%-11.527-11.5270%11.342-202%12.340-193%41.708-128%
Price Per Share7.600-22%9.2879.2870%12.894-28%14.141-34%48.023-81%
Price To Free Cash Flow Ratio21.162-22%25.85925.8590%11.358+128%18.392+41%42.734-39%
Price To Total Gains Ratio-7.949+18%-9.714-9.7140%6.079-260%4.438-319%57.674-117%
Quick Ratio--0.9430.9430%0.815+16%0.876+8%1.013-7%
Return On Assets---0.024-0.0240%0.033-172%-0.019-19%0.012-298%
Return On Equity---0.089-0.0890%0.107-183%-0.082-8%0.020-538%
Total Gains Per Share---0.956-0.9560%2.121-145%-0.074-92%0.945-201%
Usd Book Value--35608467000.00035608467000.0000%41903839000.000-15%39483436400.000-10%37026971050.000-4%
Usd Book Value Change Per Share---1.602-1.6020%1.577-202%-0.716-55%0.336-576%
Usd Book Value Per Share--9.0619.0610%10.663-15%10.047-10%9.422-4%
Usd Dividend Per Share--0.6460.6460%0.544+19%0.642+1%0.609+6%
Usd Eps---0.806-0.8060%1.137-171%-0.230-71%0.492-264%
Usd Free Cash Flow--1411291500.0001411291500.0000%4461016000.000-68%3439417500.000-59%4455633500.000-68%
Usd Free Cash Flow Per Share--0.3590.3590%1.135-68%0.875-59%1.134-68%
Usd Free Cash Flow To Equity Per Share--0.5980.5980%-0.021+103%-0.054+109%1.408-58%
Usd Market Cap29865720729.600-22%36495124791.55236495124791.5520%50669553037.824-28%55569889057.536-34%188716066304.210-81%
Usd Price Per Share7.600-22%9.2879.2870%12.894-28%14.141-34%48.023-81%
Usd Profit---3165986500.000-3165986500.0000%4467475000.000-171%-2351506600.000-26%655373200.000-583%
Usd Revenue--51281230500.00051281230500.0000%54620533500.000-6%48959650600.000+5%47079112750.000+9%
Usd Total Gains Per Share---0.956-0.9560%2.121-145%-0.074-92%0.945-201%
 EOD+4 -4MRQTTM+0 -0YOY+12 -245Y+13 -2310Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Bayer AG PK based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.433
Price to Book Ratio (EOD)Between0-10.839
Net Profit Margin (MRQ)Greater than0-0.062
Operating Margin (MRQ)Greater than00.177
Quick Ratio (MRQ)Greater than10.943
Current Ratio (MRQ)Greater than11.259
Debt to Asset Ratio (MRQ)Less than10.732
Debt to Equity Ratio (MRQ)Less than12.741
Return on Equity (MRQ)Greater than0.15-0.089
Return on Assets (MRQ)Greater than0.05-0.024
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Bayer AG PK based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.098
Ma 20Greater thanMa 507.301
Ma 50Greater thanMa 1007.374
Ma 100Greater thanMa 2007.977
OpenGreater thanClose7.660
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets123,344,000
Total Liabilities90,266,000
Total Stockholder Equity32,927,000
 As reported
Total Liabilities 90,266,000
Total Stockholder Equity+ 32,927,000
Total Assets = 123,344,000

Assets

Total Assets123,344,000
Total Current Assets37,090,000
Long-term Assets86,254,000
Total Current Assets
Cash And Cash Equivalents 5,907,000
Short-term Investments 4,685,000
Net Receivables 12,500,000
Inventory 13,947,000
Other Current Assets 51,000
Total Current Assets  (as reported)37,090,000
Total Current Assets  (calculated)37,090,000
+/-0
Long-term Assets
Property Plant Equipment 13,321,000
Goodwill 32,299,000
Intangible Assets 23,363,000
Other Assets 10,201,000
Long-term Assets  (as reported)86,254,000
Long-term Assets  (calculated)79,184,000
+/- 7,070,000

Liabilities & Shareholders' Equity

Total Current Liabilities29,457,000
Long-term Liabilities60,809,000
Total Stockholder Equity32,927,000
Total Current Liabilities
Short-term Debt 6,613,000
Short Long Term Debt 4,410,000
Accounts payable 7,456,000
Other Current Liabilities 11,477,000
Total Current Liabilities  (as reported)29,457,000
Total Current Liabilities  (calculated)29,956,000
+/- 499,000
Long-term Liabilities
Long term Debt 37,226,000
Capital Lease Obligations 1,238,000
Other Liabilities 15,548,000
Long-term Liabilities Other 928,000
Deferred Long Term Liability 3,558,000
Long-term Liabilities  (as reported)60,809,000
Long-term Liabilities  (calculated)58,498,000
+/- 2,311,000
Total Stockholder Equity
Common Stock2,515,000
Retained Earnings 12,175,000
Accumulated Other Comprehensive Income -24,000
Other Stockholders Equity 18,261,000
Total Stockholder Equity (as reported)32,927,000
Total Stockholder Equity (calculated)32,927,000
+/-0
Other
Capital Stock2,515,000
Cash and Short Term Investments 10,592,000
Common Stock Shares Outstanding 982,420
Current Deferred Revenue3,911,000
Liabilities and Stockholders Equity 123,344,000
Net Debt 38,882,000
Net Invested Capital 74,563,000
Net Tangible Assets -19,194,000
Net Working Capital 8,099,000
Property Plant and Equipment Gross 29,257,000
Short Long Term Debt Total 44,789,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
> Total Assets 
29,377,000
31,279,000
36,552,524
37,103,641
41,729,603
37,379,756
37,775,855
36,694,557
55,891,003
51,378,000
52,511,000
51,042,000
51,506,000
52,765,000
51,336,000
51,317,000
70,234,000
73,917,000
82,238,000
75,087,000
126,285,000
126,258,000
117,046,000
120,241,000
124,877,000
123,344,000
123,344,000124,877,000120,241,000117,046,000126,258,000126,285,00075,087,00082,238,00073,917,00070,234,00051,317,00051,336,00052,765,00051,506,00051,042,00052,511,00051,378,00055,891,00336,694,55737,775,85537,379,75641,729,60337,103,64136,552,52431,279,00029,377,000
   > Total Current Assets 
14,734,000
15,041,000
15,499,420
14,475,961
16,905,688
17,641,759
19,532,291
16,579,715
19,993,924
16,666,000
17,160,000
16,993,000
18,318,000
20,068,000
18,986,000
19,028,000
22,227,000
23,821,000
30,447,000
30,073,000
30,933,000
32,559,000
35,660,000
32,578,000
37,760,000
37,090,000
37,090,00037,760,00032,578,00035,660,00032,559,00030,933,00030,073,00030,447,00023,821,00022,227,00019,028,00018,986,00020,068,00018,318,00016,993,00017,160,00016,666,00019,993,92416,579,71519,532,29117,641,75916,905,68814,475,96115,499,42015,041,00014,734,000
       Cash And Cash Equivalents 
-4,730,000
-4,466,000
491,910
720,426
768,094
2,729,081
3,567,420
3,287,743
2,914,833
2,531,000
2,094,000
2,725,000
2,840,000
1,770,000
1,695,000
1,662,000
1,853,000
1,859,000
1,899,000
7,581,000
4,052,000
3,185,000
4,191,000
4,564,000
5,171,000
5,907,000
5,907,0005,171,0004,564,0004,191,0003,185,0004,052,0007,581,0001,899,0001,859,0001,853,0001,662,0001,695,0001,770,0002,840,0002,725,0002,094,0002,531,0002,914,8333,287,7433,567,4202,729,081768,094720,426491,910-4,466,000-4,730,000
       Short-term Investments 
6,451,000
0
214,013
51,700
28,589
128,633
28,770
233,030
69,707
335,000
634,000
367,000
1,008,000
2,784,000
339,000
138,000
154,000
272,000
3,525,000
1,517,000
285,000
2,219,000
7,692,000
3,175,000
4,982,000
4,685,000
4,685,0004,982,0003,175,0007,692,0002,219,000285,0001,517,0003,525,000272,000154,000138,000339,0002,784,0001,008,000367,000634,000335,00069,707233,03028,770128,63328,58951,700214,01306,451,000
       Net Receivables 
7,232,000
11,375,000
8,018,557
7,427,921
0
0
8,177,920
6,620,235
7,930,741
7,499,000
7,743,000
7,810,000
8,366,000
0
0
9,256,000
11,027,000
13,175,500
15,584,000
14,367,000
14,137,000
14,449,000
12,058,000
12,860,000
13,450,000
12,500,000
12,500,00013,450,00012,860,00012,058,00014,449,00014,137,00014,367,00015,584,00013,175,50011,027,0009,256,000008,366,0007,810,0007,743,0007,499,0007,930,7416,620,2358,177,920007,427,9218,018,55711,375,0007,232,000
       Inventory 
5,781,000
4,992,000
6,111,608
5,827,473
6,347,733
5,875,028
6,210,528
5,499,835
6,153,200
6,217,000
6,681,000
6,091,000
6,104,000
6,368,000
6,967,000
7,114,000
8,384,000
8,537,000
8,387,000
6,537,000
9,831,000
10,765,000
10,954,000
11,270,000
13,595,000
13,947,000
13,947,00013,595,00011,270,00010,954,00010,765,0009,831,0006,537,0008,387,0008,537,0008,384,0007,114,0006,967,0006,368,0006,104,0006,091,0006,681,0006,217,0006,153,2005,499,8356,210,5285,875,0286,347,7335,827,4736,111,6084,992,0005,781,000
   > Long-term Assets 
14,643,000
16,238,000
21,053,104
22,627,680
24,823,916
19,737,998
18,243,564
20,114,841
35,897,079
34,712,000
35,351,000
34,049,000
33,188,000
32,697,000
32,350,000
32,289,000
48,007,000
50,096,000
51,791,000
45,014,000
95,352,000
93,699,000
81,386,000
87,663,000
87,117,000
86,254,000
86,254,00087,117,00087,663,00081,386,00093,699,00095,352,00045,014,00051,791,00050,096,00048,007,00032,289,00032,350,00032,697,00033,188,00034,049,00035,351,00034,712,00035,897,07920,114,84118,243,56419,737,99824,823,91622,627,68021,053,10416,238,00014,643,000
       Property Plant Equipment 
10,970,000
11,986,000
13,381,652
13,566,718
12,447,694
9,919,817
9,177,477
8,314,765
8,867,246
8,819,000
9,492,000
9,409,000
9,835,000
9,823,000
9,863,000
10,015,000
11,428,000
12,375,000
13,114,000
7,633,000
12,944,000
12,479,000
11,710,000
12,688,000
13,674,000
13,321,000
13,321,00013,674,00012,688,00011,710,00012,479,00012,944,0007,633,00013,114,00012,375,00011,428,00010,015,0009,863,0009,823,0009,835,0009,409,0009,492,0008,819,0008,867,2468,314,7659,177,4779,919,81712,447,69413,566,71813,381,65211,986,00010,970,000
       Goodwill 
0
0
980,626
867,848
3,002,904
5,698,883
2,541,083
3,106,157
8,226,998
8,215,000
12,035,759
12,474,572
11,944,754
11,883,268
9,293,000
9,862,000
16,168,000
16,096,000
16,312,000
14,751,000
38,146,000
39,126,000
36,080,000
40,106,000
39,648,000
32,299,000
32,299,00039,648,00040,106,00036,080,00039,126,00038,146,00014,751,00016,312,00016,096,00016,168,0009,862,0009,293,00011,883,26811,944,75412,474,57212,035,7598,215,0008,226,9983,106,1572,541,0835,698,8833,002,904867,848980,62600
       Long Term Investments 
0
0
0
0
0
0
2,256,718
2,775,049
2,364,657
0
0
0
0
0
0
430,000
1,187,000
1,329,279
2,872,403
39,522,850
12,121,302
6,983,351
0
0
0
0
00006,983,35112,121,30239,522,8502,872,4031,329,2791,187,000430,0000000002,364,6572,775,0492,256,718000000
       Intangible Assets 
0
0
3,875,654
5,022,754
8,887,398
6,502,312
6,012,830
7,682,377
15,806,929
14,555,000
31,454,156
30,879,726
26,754,285
25,238,971
9,464,000
8,914,000
15,653,000
15,178,000
13,567,000
11,674,000
36,746,000
34,709,000
26,029,000
26,258,000
24,183,000
23,363,000
23,363,00024,183,00026,258,00026,029,00034,709,00036,746,00011,674,00013,567,00015,178,00015,653,0008,914,0009,464,00025,238,97126,754,28530,879,72631,454,15614,555,00015,806,9297,682,3776,012,8306,502,3128,887,3985,022,7543,875,65400
       Long-term Assets Other 
276,000
217,000
2,400,989
3,429,049
2,520,606
2,020,012
1,819,119
2,420,637
1,791,179
2,129,000
458,000
549,000
498,000
3,209,000
1,884,000
1,581,000
1,439,000
816,000
4,220,000
2,283,000
843,000
3,044,000
8,575,000
4,594,000
6,094,000
1,269,000
1,269,0006,094,0004,594,0008,575,0003,044,000843,0002,283,0004,220,000816,0001,439,0001,581,0001,884,0003,209,000498,000549,000458,0002,129,0001,791,1792,420,6371,819,1192,020,0122,520,6063,429,0492,400,989217,000276,000
> Total Liabilities 
16,598,000
16,097,000
20,129,974
20,053,926
26,260,994
25,065,145
25,406,437
25,790,293
43,039,823
34,557,000
36,171,000
32,091,000
32,610,000
33,494,000
32,767,000
30,513,000
50,016,000
48,472,000
50,341,000
38,226,000
80,137,000
78,741,000
86,347,000
87,073,000
85,951,000
90,266,000
90,266,00085,951,00087,073,00086,347,00078,741,00080,137,00038,226,00050,341,00048,472,00050,016,00030,513,00032,767,00033,494,00032,610,00032,091,00036,171,00034,557,00043,039,82325,790,29325,406,43725,065,14526,260,99420,053,92620,129,97416,097,00016,598,000
   > Total Current Liabilities 
7,454,000
6,808,000
9,880,787
9,627,413
9,778,425
9,370,348
9,880,486
9,062,824
15,515,218
10,612,000
13,835,000
8,973,000
10,835,000
13,390,000
13,099,000
14,023,000
15,503,000
16,980,000
18,537,000
13,593,000
22,823,000
23,215,000
36,728,000
29,403,000
35,084,000
29,457,000
29,457,00035,084,00029,403,00036,728,00023,215,00022,823,00013,593,00018,537,00016,980,00015,503,00014,023,00013,099,00013,390,00010,835,0008,973,00013,835,00010,612,00015,515,2189,062,8249,880,4869,370,3489,778,4259,627,4139,880,7876,808,0007,454,000
       Short-term Debt 
2,326,000
2,107,000
3,872,459
4,316,938
2,843,662
2,309,039
2,603,273
991,220
3,393,694
1,107,000
5,808,000
1,226,000
1,460,000
3,235,000
2,205,000
2,160,000
1,443,000
2,468,000
2,889,000
1,050,000
2,958,000
1,975,000
8,360,000
3,053,000
7,539,000
6,613,000
6,613,0007,539,0003,053,0008,360,0001,975,0002,958,0001,050,0002,889,0002,468,0001,443,0002,160,0002,205,0003,235,0001,460,0001,226,0005,808,0001,107,0003,393,694991,2202,603,2732,309,0392,843,6624,316,9383,872,4592,107,0002,326,000
       Short Long Term Debt 
0
0
0
0
0
0
3,554,262
2,092,835
6,704,483
0
0
0
0
0
0
9,031,000
1,890,000
3,651,173
2,830,000
1,018,000
2,908,000
1,676,000
8,148,000
2,817,000
7,257,000
4,410,000
4,410,0007,257,0002,817,0008,148,0001,676,0002,908,0001,018,0002,830,0003,651,1731,890,0009,031,0000000006,704,4832,092,8353,554,262000000
       Accounts payable 
1,613,000
1,556,000
2,021,941
1,996,064
2,535,853
2,261,397
2,274,267
1,972,308
2,369,297
2,466,000
2,377,000
2,735,000
3,497,000
3,779,000
4,295,000
4,473,000
5,363,000
5,945,000
6,410,000
5,129,000
5,414,000
6,426,000
5,683,000
6,792,000
7,545,000
7,456,000
7,456,0007,545,0006,792,0005,683,0006,426,0005,414,0005,129,0006,410,0005,945,0005,363,0004,473,0004,295,0003,779,0003,497,0002,735,0002,377,0002,466,0002,369,2971,972,3082,274,2672,261,3972,535,8531,996,0642,021,9411,556,0001,613,000
       Other Current Liabilities 
3,515,000
3,145,000
3,940,603
3,314,411
4,398,910
4,799,911
5,002,946
4,083,927
8,106,525
3,049,000
1,961,000
1,567,000
1,946,000
1,630,000
406,000
377,000
632,000
347,000
686,000
606,000
4,283,000
5,146,000
5,037,000
5,245,000
7,948,000
11,477,000
11,477,0007,948,0005,245,0005,037,0005,146,0004,283,000606,000686,000347,000632,000377,000406,0001,630,0001,946,0001,567,0001,961,0003,049,0008,106,5254,083,9275,002,9464,799,9114,398,9103,314,4113,940,6033,145,0003,515,000
   > Long-term Liabilities 
9,144,000
9,289,000
10,249,187
10,426,513
16,482,569
15,694,797
15,525,951
16,727,470
27,524,605
23,945,000
22,336,000
23,118,000
21,775,000
20,104,000
19,668,000
16,490,000
34,513,000
31,492,000
31,804,000
24,633,000
57,314,000
55,526,000
49,619,000
57,670,000
50,867,000
60,809,000
60,809,00050,867,00057,670,00049,619,00055,526,00057,314,00024,633,00031,804,00031,492,00034,513,00016,490,00019,668,00020,104,00021,775,00023,118,00022,336,00023,945,00027,524,60516,727,47015,525,95115,694,79716,482,56910,426,51310,249,1879,289,0009,144,000
       Other Liabilities 
0
0
6,807,239
5,428,720
7,020,756
9,003,076
9,710,807
10,695,694
11,159,383
10,467,430
11,316,146
11,995,883
12,190,230
12,884,784
15,517,285
13,375,275
18,562,934
16,267,376
15,624,000
12,150,000
19,747,000
18,614,000
16,160,000
21,189,000
17,076,000
15,548,000
15,548,00017,076,00021,189,00016,160,00018,614,00019,747,00012,150,00015,624,00016,267,37618,562,93413,375,27515,517,28512,884,78412,190,23011,995,88311,316,14610,467,43011,159,38310,695,6949,710,8079,003,0767,020,7565,428,7206,807,23900
       Deferred Long Term Liability 
0
0
0
0
0
0
2,580,080
331,632
5,738,024
0
0
0
0
0
0
673,000
753,000
822,111
843,000
1,033,000
5,253,000
5,517,000
4,383,000
4,312,000
3,797,000
3,558,000
3,558,0003,797,0004,312,0004,383,0005,517,0005,253,0001,033,000843,000822,111753,000673,0000000005,738,024331,6322,580,080000000
> Total Stockholder Equity
12,568,000
15,006,000
16,185,113
16,951,935
15,348,535
12,191,537
12,258,766
10,824,054
12,767,077
16,734,000
16,263,000
18,897,000
18,833,000
19,212,000
18,469,000
20,718,000
20,106,000
24,265,000
30,333,000
36,801,000
45,977,000
47,337,000
30,524,000
33,020,000
38,773,000
32,927,000
32,927,00038,773,00033,020,00030,524,00047,337,00045,977,00036,801,00030,333,00024,265,00020,106,00020,718,00018,469,00019,212,00018,833,00018,897,00016,263,00016,734,00012,767,07710,824,05412,258,76612,191,53715,348,53516,951,93516,185,11315,006,00012,568,000
   Common Stock
1,867,000
1,870,000
1,875,007
1,873,558
1,871,633
1,866,765
1,868,543
1,868,458
1,957,113
1,957,000
1,957,000
2,117,000
2,117,000
2,117,000
2,117,000
2,117,000
2,117,000
2,117,000
2,117,000
2,117,000
2,387,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,0002,515,0002,515,0002,515,0002,515,0002,387,0002,117,0002,117,0002,117,0002,117,0002,117,0002,117,0002,117,0002,117,0002,117,0001,957,0001,957,0001,957,1131,868,4581,868,5431,866,7651,871,6331,873,5581,875,0071,870,0001,867,000
   Retained Earnings 
7,121,000
7,965,000
9,071,585
10,824,377
11,145,937
10,460,551
8,746,672
6,393,960
9,061,060
15,696,765
14,305,948
15,210,552
13,997,469
14,176,895
13,429,941
17,132,808
14,305,802
18,007,168
18,393,000
26,851,000
25,734,000
26,151,000
13,057,000
13,345,000
17,233,000
12,175,000
12,175,00017,233,00013,345,00013,057,00026,151,00025,734,00026,851,00018,393,00018,007,16814,305,80217,132,80813,429,94114,176,89513,997,46915,210,55214,305,94815,696,7659,061,0606,393,9608,746,67210,460,55111,145,93710,824,3779,071,5857,965,0007,121,000
   Accumulated Other Comprehensive Income 
-979,000
0
0
0
0
0
0
0
0
0
14,306,000
16,780,000
16,716,000
0
0
0
0
0
0
0
0
26,493,000
-3,310,000
-1,101,000
764,000
-24,000
-24,000764,000-1,101,000-3,310,00026,493,0000000000016,716,00016,780,00014,306,000000000000-979,000
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
4,559,000
5,171,000
5,238,521
4,253,999
2,330,965
-135,779
1,643,551
2,561,637
10,809,963
14,777,000
0
0
0
17,095,000
16,352,000
18,601,000
17,989,000
22,148,000
28,216,000
34,684,000
43,590,000
18,329,000
18,262,000
18,261,000
18,261,000
18,261,000
18,261,00018,261,00018,261,00018,262,00018,329,00043,590,00034,684,00028,216,00022,148,00017,989,00018,601,00016,352,00017,095,00000014,777,00010,809,9632,561,6371,643,551-135,7792,330,9654,253,9995,238,5215,171,0004,559,000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue47,637,000
Cost of Revenue-19,749,000
Gross Profit27,888,00027,888,000
 
Operating Income (+$)
Gross Profit27,888,000
Operating Expense-19,479,000
Operating Income8,409,0008,409,000
 
Operating Expense (+$)
Research Development5,371,000
Selling General Administrative2,453,000
Selling And Marketing Expenses12,482,000
Operating Expense19,479,00020,306,000
 
Net Interest Income (+$)
Interest Income484,000
Interest Expense-1,788,000
Other Finance Cost-307,000
Net Interest Income-1,611,000
 
Pretax Income (+$)
Operating Income8,409,000
Net Interest Income-1,611,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,459,00018,277,000
EBIT - interestExpense = 6,621,000
-1,620,000
-1,153,000
Interest Expense1,788,000
Earnings Before Interest and Taxes (EBIT)8,409,000329,000
Earnings Before Interest and Taxes (EBITDA)12,342,000
 
After tax Income (+$)
Income Before Tax-1,459,000
Tax Provision-1,321,000
Net Income From Continuing Ops-2,942,000-2,780,000
Net Income-2,941,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses39,228,000
Total Other Income/Expenses Net-9,868,0001,611,000
 

Technical Analysis of Bayer
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bayer. The general trend of Bayer is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bayer's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bayer AG PK.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.901 < 8.05 < 8.335.

The bearish price targets are: 6.96.

Tweet this
Bayer AG PK Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bayer AG PK. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bayer AG PK Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bayer AG PK. The current macd is 0.01978227.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bayer price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bayer. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bayer price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bayer AG PK Daily Moving Average Convergence/Divergence (MACD) ChartBayer AG PK Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bayer AG PK. The current adx is 16.95.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Bayer shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bayer AG PK Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bayer AG PK. The current sar is 7.05149154.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bayer AG PK Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bayer AG PK. The current rsi is 59.10. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Bayer AG PK Daily Relative Strength Index (RSI) ChartBayer AG PK Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bayer AG PK. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bayer price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Bayer AG PK Daily Stochastic Oscillator ChartBayer AG PK Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bayer AG PK. The current cci is 145.62.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Bayer AG PK Daily Commodity Channel Index (CCI) ChartBayer AG PK Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bayer AG PK. The current cmo is 30.73.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bayer AG PK Daily Chande Momentum Oscillator (CMO) ChartBayer AG PK Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bayer AG PK. The current willr is -12.32876712.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Bayer AG PK Daily Williams %R ChartBayer AG PK Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bayer AG PK.

Bayer AG PK Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bayer AG PK. The current atr is 0.18076138.

Bayer AG PK Daily Average True Range (ATR) ChartBayer AG PK Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bayer AG PK. The current obv is -45,773,720.

Bayer AG PK Daily On-Balance Volume (OBV) ChartBayer AG PK Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bayer AG PK. The current mfi is 48.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bayer AG PK Daily Money Flow Index (MFI) ChartBayer AG PK Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bayer AG PK.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Bayer AG PK Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bayer AG PK based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.098
Ma 20Greater thanMa 507.301
Ma 50Greater thanMa 1007.374
Ma 100Greater thanMa 2007.977
OpenGreater thanClose7.660
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bayer with someone you think should read this too:
  • Are you bullish or bearish on Bayer? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bayer? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bayer AG PK

I send you an email if I find something interesting about Bayer AG PK.


Comments

How you think about this?

Leave a comment

Stay informed about Bayer AG PK.

Receive notifications about Bayer AG PK in your mailbox!